VC-backed GlycoMimetics files for IPO

GlycoMimetics said Monday that it has filed an IPO. The number of shares and the price range have yet to be set. The stock will trade on the NASDAQ under the ticker symbol “GLYC.” Jefferies and Barclays Capital are serving as lead underwriters. Based in Gaithersburg, MD, GlycoMimetics is a biotech company focused on developing glycomimetic drugs. It is backed by New Enterprise Associates, Genzyme Ventures, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures.

DealsNorth AmericaUSBriefs